Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
If you have a really innovative idea that might impact the diagnosis and treatment of prostate cancer, now’s the time to get your proposal in to GE and its venture capital partners.
Filed under: Diagnosis, Management, Treatment | Tagged: detection, Diagnosis, GE, Treatment | 2 Comments »
For many years a relatively small group of specialists have argued that “enhanced” types of transrectal ultrasound technology (most specifically inclusive of color Döppler ultrasound) have a greater ability to identify possible signs of prostate cancer than traditional “gray-scale” ultrasound.
Filed under: Diagnosis | Tagged: biopsy, detection, Diagnosis, ultrasound | 4 Comments »
In early 1990, Dr. Gerry Chodak — a well-known Chicago-based urologist and then professor of urology at The University of Chicago — wrote a letter to his prostate cancer patients. He said that some of them were interested in starting a prostate cancer support group. From such small beginnings …
Filed under: Uncategorized | Tagged: advocacy, detection, education, research, support, Us TOO International | Leave a Comment »
On Thursday we provided an initial summary of media-reported data from the paper just published by Hugosson et al. in Lancet Oncology. Following is a carefully considered analysis after receipt and study of a copy of the full paper and additional information.
Filed under: Diagnosis, Management, Risk | Tagged: detection, mortality, risk, screening, survival | 31 Comments »
Data from a small study at the University of California at San Francisco suggest that magnetic resonance (MR) spectroscopic imaging is better than T2-weighted MR imaging alone for the detection of locally recurrent prostate cancer after definitive external beam radiation therapy (EBRT) as first-line therapy.
Filed under: Management, Treatment | Tagged: detection, magentic resonance imaging, MRI, recurrence | Leave a Comment »
We are starting to see a increase in the publication of data about [-2]proPSA — a specific type or isoform of free PSA – and its potential relevance in the detection and diagnosis of prostate cancer.
Filed under: Diagnosis, Risk, Uncategorized | Tagged: aggressiveness, biopsy, detection, [-2]proPSA | Leave a Comment »
Nogueira et al. have just published a new “mini-review” in BJU International that addresses the potential roles of current and “future” biomarkers that may have relevance to prostate cancer detection.
Filed under: Diagnosis, Risk | Tagged: biomarkers, detection | Leave a Comment »
Today’s news reports address issues such as: Pro-PSA (a pecursor molecule to PSA itself) A review of development-stage markers for prostate cancer detection Understanding the pathology report A Phase I trial of high-dose testosterone in men with metatstatic CRPC
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: atypia, detection, markers, pathology, pro-PSA, risk, testosterone therapy | Leave a Comment »
There are multiple news reports available today, including coverage of the following: Vegetable consumption and prostate cancer risk Anti-hypertensive medications and prostate cancer risk Prostate cancer incidence among South Indian and Pakistani immigrants to the United States Bladder neck contracture and type of surgery Cytotoxic and targeted chemotherapies in the managment of prostate cancer The [...]
Filed under: Diagnosis, Living with Prostate Cancer, Management, Prevention, Risk, Treatment | Tagged: anti-hypertensives, bladder neck contracture, chemotherapy, choice, cytotoxic, detection, immigrants, Indian, Pakistani, race, risk, targeted, USA, vegetables | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site